![Disparate regulatory status of methylphenidate for adults with ADHD across Europe - The Lancet Psychiatry Disparate regulatory status of methylphenidate for adults with ADHD across Europe - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/991416e6-9488-4964-b5ef-7376785556ac/gr1_lrg.jpg)
Disparate regulatory status of methylphenidate for adults with ADHD across Europe - The Lancet Psychiatry
![Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study - The Lancet Child & Adolescent Health Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/asset/481d7d86-ef00-4313-a441-761c3b90fef6/gr1.jpg)
Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study - The Lancet Child & Adolescent Health
![Ritalin Versus Adderall Versus Concerta: Which ADHD Drugs Pose the Most Risk for Abuse? | Ashwood Recovery Ritalin Versus Adderall Versus Concerta: Which ADHD Drugs Pose the Most Risk for Abuse? | Ashwood Recovery](https://www.ashwoodrecovery.com/images/blog/wp-content/uploads/2017/07/Ritalin-vs-Adderall_03.png)